Crinetics Pharmaceuticals Stock In The News
| CRNX Stock | USD 34.47 0.57 1.63% |
Our overall analysis of Crinetics Pharmaceuticals' news coverage and content from conventional and social sources shows investors' bearish mood towards Crinetics Pharmaceuticals. The specific impact of Crinetics Pharmaceuticals news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Crinetics Pharmaceuticals' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Crinetics Pharmaceuticals headlines in addition to utilizing other, more conventional financial analysis modules. Check out Crinetics Pharmaceuticals Backtesting and Crinetics Pharmaceuticals Hype Analysis. For more information on how to buy Crinetics Stock please use our How to Invest in Crinetics Pharmaceuticals guide.
Crinetics |
Crinetics Pharmaceuticals Today Top News and Investor Outlook
Crinetics Pharmaceuticals Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Crinetics and other traded companies coverage with news coverage. We help investors stay connected with Crinetics headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Crinetics Stock performance. Please note that trading solely based on the Crinetics Pharmaceuticals hype is not for everyone as timely availability and quick action are needed to avoid losses.
Crinetics Pharmaceuticals stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Crinetics earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Crinetics Pharmaceuticals that are available to investors today. That information is available publicly through Crinetics media outlets and privately through word of mouth or via Crinetics internal channels. However, regardless of the origin, that massive amount of Crinetics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Crinetics Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Crinetics Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Crinetics Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Crinetics Pharmaceuticals alpha.
Crinetics Largest EPS Surprises
Earnings surprises can significantly impact Crinetics Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2018-11-13 | 2018-09-30 | -0.34 | -0.38 | -0.04 | 11 | ||
2019-08-13 | 2019-06-30 | -0.46 | -0.51 | -0.05 | 10 | ||
2019-03-13 | 2018-12-31 | -0.41 | -0.35 | 0.06 | 14 | ||
2021-03-30 | 2020-12-31 | -0.58 | -0.66 | -0.08 | 13 | ||
2020-05-08 | 2020-03-31 | -0.63 | -0.71 | -0.08 | 12 | ||
2020-03-09 | 2019-12-31 | -0.68 | -0.6 | 0.08 | 11 |
Crinetics Pharmaceuticals Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Crinetics Pharmaceuticals Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
10th of March 2025
Acquisition by Tobin Schilke of 52000 shares of Crinetics Pharmaceuticals subject to Rule ... at gurufocus.com
5th of March 2025
Insider Trading at MacroaxisInsider
28th of February 2025
Insider Trading at gurufocus.com
27th of February 2025
Is Crinetics Pharmaceuticals the Worst Performing Mid Cap Stock to Buy According to Analys... at finance.yahoo.com
26th of February 2025
What To Expect From Crinetics Pharmaceuticals Inc Q4 2024 Earnings at gurufocus.com
24th of February 2025
Acquisition by Struthers Richard Scott of 313000 shares of Crinetics Pharmaceuticals at 36... at gurufocus.com
10th of February 2025
Crinetics Pharmaceuticals Inc Announces Stock Option and RSU Awards for New Employees at gurufocus.com
15th of January 2025
Why Crinetics Pharmaceuticals Stock is Undergoing a Shake-Up - TipRanks at news.google.com
16th of December 2024
Crinetics Pharmaceuticals Appoints Isabel Kalofonos asChief Com at gurufocus.com
Crinetics Pharmaceuticals Investors Sentiment
The influence of Crinetics Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Crinetics. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Crinetics Pharmaceuticals' public news can be used to forecast risks associated with an investment in Crinetics. The trend in average sentiment can be used to explain how an investor holding Crinetics can time the market purely based on public headlines and social activities around Crinetics Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Crinetics Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Crinetics Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Crinetics Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Crinetics Pharmaceuticals.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Crinetics Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Crinetics Pharmaceuticals' short interest history, or implied volatility extrapolated from Crinetics Pharmaceuticals options trading.
Additional Tools for Crinetics Stock Analysis
When running Crinetics Pharmaceuticals' price analysis, check to measure Crinetics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crinetics Pharmaceuticals is operating at the current time. Most of Crinetics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Crinetics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crinetics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Crinetics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.